HLA-DRB1 and malaria: We carried out systematic identification and verification of predicted class II T cell epitopes for five Pf blood stage antigen vaccine targets to better enable blood stage malaria vaccine design through identification and validation of highly promiscuous HLA-DRB1-restricted epitope clusters.